0001225208-20-012815.txt : 20201029
0001225208-20-012815.hdr.sgml : 20201029
20201029205050
ACCESSION NUMBER: 0001225208-20-012815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201029
FILED AS OF DATE: 20201029
DATE AS OF CHANGE: 20201029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szyman Catherine M.
CENTRAL INDEX KEY: 0001438538
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 201274406
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER NAME:
FORMER CONFORMED NAME: Szyman Catherine M
DATE OF NAME CHANGE: 20080625
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2020-10-29
0001099800
Edwards Lifesciences Corp
EW
0001438538
Szyman Catherine M.
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, Critical Care
Common Stock
2020-10-29
4
M
0
20355.0000
22.2867
A
47101.1397
D
Common Stock
2020-10-29
4
S
0
20355.0000
73.2441
D
26746.1397
D
Employee Stock Option (Right to Acquire)
22.2867
2020-10-29
4
M
0
20355.0000
0.0000
D
2016-02-19
2022-02-18
Common Stock
20355.0000
20355.0000
D
This transaction was executed in multiple trades at prices ranging from $72.9800 to $73.4300. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2020-10-29